IMUN

Immune Therapeutics, Inc. IMUN

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IMUN TBPMF FWPAY POLXF BNOEF MXDHF TRYPF HBCNF TPPRF IPCIF
6M -81.40 % -95.45 % 14 900.00 % 261.09 % -71.43 % 24 900.00 % 51.48 % -76.19 % 0.00 % 604.23 %
YTD -84.50 % -95.50 % -25.00 % 261.09 % -70.00 % -96.03 % 63.61 % 2 269.67 % 0.00 % 178.29 %
1Y -91.14 % -96.25 % -68.31 % 133.65 % -85.52 % -95.83 % -4.75 % -66.67 % 0.00 % 233.33 %
3Y -99.42 % -99.26 % -86.82 % 133.65 % -94.20 % -97.40 % -89.87 % -84.62 % 0.00 % 25.00 %
5Y -98.89 % -99.90 % -90.06 % 85.61 % -95.00 % -98.63 % -92.86 % -84.62 % 0.00 % -11.76 %
10Y -100.00 % -97.80 % -99.27 % 145.19 % -98.95 % -99.61 % -92.86 % -84.62 % 0.00 % -99.48 %
From the beginning -99.99 % -99.71 % -99.27 % -95.65 % -98.13 % -99.61 % -92.86 % -84.62 % 0.00 % -99.70 %

Dividend

Forward Pharma A/S